Possible role of androgen receptor gene in therapeutic response of infertile men with hypogonadotropic hypogonadism

References

• Achermann JC, Jameson JL. 1999. Fertility and infertility: genetic contributions from the hypothalamic-pituitary- gonadal axis. Mol Endocrinol. 13(6):812–818.
   PubMedGoogle Scholar
• Albertelli MA, Scheller A, Brogley M, Robins DM. 2006. Replacing the mouse androgen receptor with human alleles demonstrates glutamine tract length-dependent effects on physiology and tumorigenesis in mice. Mol Endocrinol 20(6):1248–1260.
   PubMedGoogle Scholar
• Alen P, Claessens F, Verhoeven G, Rombauts W, Peeters B. 1999. The androgen receptor amino-terminal domain plays a key role in p160 coactivator-stimulated gene transcription. Mol Cell Biol. 19(9):6085–6097.
   PubMed Web of Science ®Google Scholar
• Beitel LK, Alvarado C, Mokhtar S, Paliouras M, Trifiro M. 2013. Mechanisms mediating spinal and bulbar muscular atrophy: investigations into polyglutamine-expanded androgen receptor function and dysfunction. Front Neurol. 4:53.
   PubMed Web of Science ®Google Scholar
• Bhasin S, Brito JP, Cunningham GR, Hayes FJ, Hodis HN, Matsumoto AM, Snyder PJ, Swerdloff RS, Wu FC, Yialamas MA. 2018 May 1. Testosterone therapy in men with hypogonadism: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 103(5):1715–1744. doi:10.1210/jc.2018-00229
   PubMed Web of Science ®Google Scholar
• Bhasin S, Cunningham GR, Hayes FJ, Matsumoto AM, Snyder PJ, Swerdloff RS, Montori VM. 2010. Testosterone therapy in men with androgen deficiency syndromes: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 95(6):2536–2559.
   PubMed Web of Science ®Google Scholar
• Bogaert V, Vanbillemont G, Taes Y, De Bacquer D, Deschepper E, Van Steen K, Kaufman J-M. 2009. Small effect of the androgen receptor gene GGN repeat polymorphism on serum testosterone levels in healthy men. Eur J Endocrinol. 161(1):171–177.
   PubMed Web of Science ®Google Scholar
• Borjian Boroujeni P, Firouzi V, Zari Moradi SH, Mokhtari P, Dehghankhalili F, Mollaahmadi F, Gourabi H, Sadighi-Gilani MA, Sabbaghian M, Mohseni MA. 2018. Study of tri-nucleotide expansions and expression of androgen receptor in infertile men with abnormal spermogram referred to royan institute. Andrologia. 50:e13121. doi:10.1111/and.13121
   PubMed Web of Science ®Google Scholar
• Bosdou JK, Venetis CA, Dafopoulos K, Zepiridis L, Chatzimeletiou K, Anifandis G, Mitsoli A, Makedos A, Messinis IE, Tarlatzis BC, et al. 2016. May. Transdermal testosterone pretreatment in poor responders undergoing ICSI: a randomized clinical trial. Hum Reprod. 31(5):977–985. doi:10.1093/humrep/dew028
   PubMed Web of Science ®Google Scholar
• Cao XW, Lin K, Li CY, Yuan CW. 2011. [A review of WHO laboratory manual for the examination and processing of human semen (5th edition)]. Zhonghua Nan Ke Xue = National J Andrology. 17(12):1059–1063.
   PubMedGoogle Scholar
• Castro‐Nallar E, Bacallao K, Parada‐Bustamante A, Lardone MC, López PV, Madariaga M, Valdevenito R, Piottante A, Ebensperger M, Castro A. 2010. Androgen receptor gene CAG and GGN repeat polymorphisms in chilean men with primary severe spermatogenic failure. J Androl. 31(6):552–559.
   PubMedGoogle Scholar
• Chamberlain NL, Driver ED, Miesfeld RL. 1994. The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function. Nucleic Acids Res. 22(15):3181–3186.
   PubMed Web of Science ®Google Scholar
• Ding D, Xu L, Menon M, Reddy G, Barrack ER. 2005. Effect of GGC (glycine) repeat length polymorphism in the human androgen receptor on androgen action. Prostate. 62(2):133–139.
   PubMed Web of Science ®Google Scholar
• Fraietta R, Zylberstejn DS, Esteves SC. 2013. Hypogonadotropic hypogonadism revisited. Clinics. 68(Suppl 1):81–88. (Sao Paulo, Brazil).
   PubMedGoogle Scholar
• Francomano D, Greco EA, Lenzi A, Aversa A. 2013. CAG repeat testing of androgen receptor polymorphism: is this necessary for the best clinical management of hypogonadism?. J Sex Med. 10(10):2373–2381.
   PubMed Web of Science ®Google Scholar
• Giagulli V, Carbone D. 2006. Hormonal control of inhibin B in men. J Endocrinol Invest. 29(8):706–713.
   PubMed Web of Science ®Google Scholar
• Giagulli V, Triggiani V, Corona G, Carbone MD, Tafaro E, Licchelli B, Resta F, Sabbà C, Maggi M, Guastamacchia E. 2012. Effectiveness of gonadotropin administration for spermatogenesis induction in hypogonadotropic hypogonadism: a possible role of androgen receptor CAG repeat polymorphism and therapeutic measures. Endocr Metab Immune Disord. Drug Targets (Formerly Current Drug Targets-Immune, Endocrine & Metabolic Disorders). 12(3):236–242.
   PubMedGoogle Scholar
• Khan HL, Bhatti S, Abbas S, Khan YL, Aslamkhan M, Gonzalez RMM, Gonzalez GR, Aydin HH, Trinidad MS. 2018. Tri-nucleotide consortium of androgen receptor is associated with low serum FSH and testosterone in asthenospermic men. Syst Biol Reprod Med. 64(2):112–121.
   PubMed Web of Science ®Google Scholar
• Lapauw B, Goemaere S, Crabbe P, Kaufman JM, Ruige JB. 2007. Is the effect of testosterone on body composition modulated by the androgen receptor gene CAG repeat polymorphism in elderly men? Eur J Endocrinol. 156(3):395–401.
   PubMed Web of Science ®Google Scholar
• Liu L, Banks SM, Barnes KM, Sherins RJ. 1988. Two-year comparison of testicular responses to pulsatile gonadotropin-releasing hormone and exogenous gonadotropins from the inception of therapy in men with isolated hypogonadotropic hypogonadism. J Clin Endocrinol Metab. 67(6):1140–1145.
   PubMed Web of Science ®Google Scholar
• Mhatre AN, Trifiro MA, Kaufman M, Kazemi-Esfarjani P, Figlewicz D, Rouleau G, Pinsky L. 1993. Reduced transcriptional regulatory competence of the androgen receptor in X–linked spinal and bulbar muscular atrophy. Nat Genet. 5(2):184.
   PubMed Web of Science ®Google Scholar
• Mosaad Y, Shahin D, Elkholy A, Mosbah A, Badawy W. 2011. CAG repeat length in androgen receptor gene and male infertility in Egyptian patients. Andrologia. 44(1):26–33.
   Google Scholar
• Mostafa T, El‐Shahid L, El Azeem A, Shaker O, Gomaa H, Abd El Hamid H. 2012. Androgen receptor‐CAG repeats in infertile Egyptian men. Andrologia. 44(3):147–151.
   PubMed Web of Science ®Google Scholar
• Rajender S, Rajani V, Gupta NJ, Chakravarty B, Singh L, Thangaraj K. 2006. No association of androgen receptor GGN repeat length polymorphism with infertility in Indian men. J Androl. 27(6):785–789.
   PubMedGoogle Scholar
• Rajpert-De Meyts E, Leffers H, Petersen JH, Andersen AG, Carlsen E, Jorgensen N, Skakkebaek NE. 2002. CAG repeat length in androgen-receptor gene and reproductive variables in fertile and infertile men. Lancet. 359(9300):44–46. (London, England).
   PubMed Web of Science ®Google Scholar
• Sato N, Hasegawa T, Hasegawa Y, Arisaka O, Ozono K, Amemiya S, Kikuchi T, Tanaka H, Harada S, Miyata I, et al. 2015. Treatment situation of male hypogonadotropic hypogonadism in pediatrics and proposal of testosterone and gonadotropins replacement therapy protocols. Clin Pediatr Endocrinol. 24(2):37–49.
   PubMedGoogle Scholar
• Sun D, Layer R, Mueller AC, Cichewicz MA, Negishi M, Paschal BM, Dutta A. 2014. Regulation of several androgen-induced genes through the repression of the miR-99a/let-7c/miR-125b-2 miRNA cluster in prostate cancer cells. Oncogene. 33(11):1448.
   PubMed Web of Science ®Google Scholar
• Tirabassi G, Corona G, Maggi M, Balercia G. 2013. Androgen receptor gene CAG repeat polymorphism regulates the metabolic effects of testosterone replacement therapy in male postsurgical hypogonadotropic hypogonadism. Int J Endocrinol. 816740. doi:10.1155/2013/816740
   PubMed Web of Science ®Google Scholar
• Tirabassi G, Delli Muti N, Buldreghini E, Lenzi A, Balercia G. 2014a. Central body fat changes in men affected by post-surgical hypogonadotropic hypogonadism undergoing testosterone replacement therapy are modulated by androgen receptor CAG polymorphism. Nutr Metab Cardiovasc Dis. 24(8):908–913.
   PubMed Web of Science ®Google Scholar
• Tirabassi G, Delli Muti N, Corona G, Maggi M, Balercia G. 2014b. Androgen receptor gene CAG repeat polymorphism independently influences recovery of male sexual function after testosterone replacement therapy in postsurgical hypogonadotropic hypogonadism. J Sex Med. 11(5):1302–1308.
   PubMed Web of Science ®Google Scholar
• Tirabassi G, Delli Muti N, Gioia A, Biagioli A, Lenzi A, Balercia G. 2014c. Effects of testosterone replacement therapy on bone metabolism in male post-surgical hypogonadotropic hypogonadism: focus on the role of androgen receptor CAG polymorphism. J Endocrinol Invest. 37(4):393–400.
   PubMed Web of Science ®Google Scholar
• Zeegers MP, Kiemeney LA, Nieder AM, Ostrer H. 2004. How strong is the association between CAG and GGN repeat length polymorphisms in the androgen receptor gene and prostate cancer risk?. Cancer Epidemiol Prev Biomarkers. 13(11):1765–1771.
   PubMed Web of Science ®Google Scholar